TMEM63B
Basic information
Region (hg38): 6:44126914-44155519
Previous symbols: [ "C6orf110" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Strong), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM63B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 1 | 34 | 0 | 1 |
Variants in TMEM63B
This is a list of pathogenic ClinVar variants found in the TMEM63B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-44134714-G-A | TMEM63B-associated disorder • Rare epilepsy | Pathogenic/Likely pathogenic (Apr 24, 2024) | ||
6-44135083-A-G | Inborn genetic diseases | Uncertain significance (Jan 04, 2022) | ||
6-44135332-C-T | Inborn genetic diseases | Uncertain significance (Dec 16, 2021) | ||
6-44135347-G-T | Uncertain significance (Feb 01, 2023) | |||
6-44136384-G-A | Inborn genetic diseases | Uncertain significance (Mar 07, 2024) | ||
6-44138502-C-T | Inborn genetic diseases | Uncertain significance (Nov 10, 2022) | ||
6-44139526-G-A | Inborn genetic diseases | Uncertain significance (Aug 01, 2022) | ||
6-44141040-C-G | Uncertain significance (Dec 21, 2023) | |||
6-44146858-C-T | Inborn genetic diseases | Uncertain significance (Jun 07, 2023) | ||
6-44146881-C-T | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
6-44146917-G-A | Inborn genetic diseases | Uncertain significance (Jun 13, 2022) | ||
6-44147387-G-A | Likely benign (Jan 19, 2024) | |||
6-44147457-C-T | Inborn genetic diseases | Uncertain significance (Sep 30, 2021) | ||
6-44148299-A-C | Inborn genetic diseases | Uncertain significance (Mar 01, 2023) | ||
6-44148309-C-T | Inborn genetic diseases | Uncertain significance (Dec 01, 2023) | ||
6-44148589-G-A | Inborn genetic diseases | Uncertain significance (Jul 14, 2023) | ||
6-44148608-A-C | Inborn genetic diseases | Uncertain significance (Dec 21, 2022) | ||
6-44148809-G-T | Uncertain significance (Dec 03, 2023) | |||
6-44148841-A-G | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
6-44148887-CCAT-C | Uncertain significance (Oct 24, 2023) | |||
6-44148909-C-G | Uncertain significance (Mar 01, 2022) | |||
6-44148919-G-A | Pathogenic (Sep 07, 2023) | |||
6-44149874-C-G | Likely pathogenic (-) | |||
6-44149887-C-T | Uncertain significance (Jan 01, 2024) | |||
6-44150581-G-A | Inborn genetic diseases | Uncertain significance (Mar 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMEM63B | protein_coding | protein_coding | ENST00000259746 | 23 | 28606 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000821 | 125735 | 0 | 8 | 125743 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.22 | 243 | 511 | 0.475 | 0.0000309 | 5448 |
Missense in Polyphen | 56 | 193.94 | 0.28874 | 2065 | ||
Synonymous | -1.14 | 234 | 213 | 1.10 | 0.0000136 | 1635 |
Loss of Function | 5.88 | 3 | 46.1 | 0.0651 | 0.00000231 | 525 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000542 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an osmosensitive calcium-permeable cation channel. {ECO:0000250}.;
- Pathway
- Fibroblast growth factor-1
(Consensus)
Intolerance Scores
- loftool
- 0.0706
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.78
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.519
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem63b
- Phenotype
- vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- ion transmembrane transport
- Cellular component
- plasma membrane;actin cytoskeleton;integral component of membrane
- Molecular function
- calcium activated cation channel activity